Research Article

Follow-Up of High-Grade Glial Tumor; Differentiation of Posttreatment Enhancement and Tumoral Enhancement by DCE-MR Perfusion

Table 4

Mean and Std deviation of T1 DCE-MRP metrics measured from TM, NNA, and CLNA are given.

T1 DCE MRP metricsMeanStd. Deviation

tm ktrans0.020.01
CLNA ktrans0.010.01
tm kep0.170.11
CLNA kep2.041.79
tm ve0.270.15
CLNA ve0.080.08
tm IAUC2.831.30
CLNA IAUC0.410.36
tm ktrans0.020.01
NNA ktrans0.010.01
tm kep0.140.07
NNA kep1.210.75
tm ve0.280.13
NNA ve0.060.08
tm IAUC2.510.97
NNA IAUC0.530.40